Avid Bioservices Inc (CDMO)

[entdoc]

The recent trial data could very well have attained statistical significance, and it is wholly unrealistic to think Rob Garnick would endorse data that has not been adequately vetted. Simply won't happen. didn't happen. On the other hand, it is not clear why they would release data without fundamental statistical analysis included with it because it takes only minutes to accomplish. Several thoughts/explanations about that, but one is that it does tend to discredit any idea that the corporation is withholding and timing the release of important information. In the unlikely case the data is proven to be insignificant statistically, it would be ethically and investigationally unacceptable. I think we're okay here, and, in fact, bought some shares this afternoon for the first time in a long time. It seems almost inevitable that we are going to see some signicant overall survial data. Almost, I said.